Vaccinating against infiltrative glioma: antigen selection, neuronal niches, and immune access
Glioma vaccines seek to direct immunity against malignant cells, including those dispersed beyond the tissue used to identify vaccine antigens. These infiltrative cells occupy neuronal, perivascular and white matter environments, where antigen expression, immune access and treatment sensitivity may differ from those in the tumor mass. In this narrative review, we examine how spatial tumor biology can guide antigen selection, vaccine platform choice, and the evaluation of antitumor immunity. We connect the pathology of diffuse invasion with evidence on neuron–glioma communication, histone mutations and glucose metabolism, tracing the steps from antigen expression to natural presentation and distinguishing systemic immunogenicity from recognition of residual cells. Histone-mutant gliomas illustrate a central difficulty: an oncogenic mutation may form a candidate antigen while shaping the tumor state in which immunity must act, yet evidence for vaccination differs across molecular entities. Studies of glucose transporter 1 similarly highlight the distinct metabolic requirements of malignant cells, myeloid cells, and effector lymphocytes. Against this background, we assess peptide, dendritic cell, nucleic acid, and viral vector approaches, with combinations designed to support immune priming or local effector function. We then propose preclinical and clinical evaluations that relate antigen coverage, presentation, and immune engagement to residual tumor control. The aim is to align vaccine design and evaluation with the biology of the infiltrative disease that remains after treatment.
Authors
- Akira Hara (ORCID: https://orcid.org/0000-0002-5554-8060)
- Hiroyuki Tomita (ORCID: https://orcid.org/0000-0002-3291-0274)
Institutions
- Gifu University (JP)
- Center for One Medicine Innovative Translational Research (JP)
- Gifu University Institute for Advanced Study (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.2005289
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00